Recent reports have identified additional genetic markers associated with heightened vulnerability to ALL, including the HLA-DRB1*04 allele, which was found in Iranian patients diagnosed with ALL (p = 0.027) [18]. This evidence concerns the gene HLA-DRB1 and acute lymphoblastic leukemia.